The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy

QR Code

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy

Antibody responses have not been fully characterised in chronically HIV/HCV patients receiving antiretroviral therapy (ART). Seventeen HIV/HCV patients receiving ART were followed for a median (range) interval of 597 (186–766) weeks. Prior to ART, HIV/HCV patients had lower levels of antibodies reac...

Full description

Bibliographic Details
Main Authors:	Lee, S., Laiman, A., French, M., Flexman, J., Watson, M., Price, Patricia
Format:	Journal Article
Published:	Academic Press 2017
Online Access:	http://hdl.handle.net/20.500.11937/54437

Similar Items

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?
by: Lee, S., et al.
Published: (2010)

Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Experimental design of a novel target to isolate HCV monoclonal antibodies
by: Brice, Sophie
Published: (2014)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART
by: Saraswati, H., et al.
Published: (2015)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2011)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2010)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

HCV genotypes in haemodialysis units: a preliminary study
by: Hamzah, Hairul Aini, et al.
Published: (2008)

HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
by: Trinder, D., et al.
Published: (2008)

Hepatitis C virus (HCV) diagnosis via microfluidics
by: Narayanamurthy, Vigneswaran, et al.
Published: (2021)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Assessment of Cox2 and CMV in patients with chronic HCV infection
by: F. Hassan, Heba, et al.
Published: (2017)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland
by: Duong, Trinh, et al.
Published: (2014)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

Development of ELISA method for primary detection of HCV using core antigen
by: Nourollahi, Shirin, et al.
Published: (2011)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Characterization of occult hepatitis c virus (hcv) infection among hemodialysis patient
by: Abdul Rahman, Siti Nurul Fazlin, et al.
Published: (2017)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle
by: Gorzin, A., et al.
Published: (2012)

The role of blood transfusion in HCV infection: a study testing Ab: RNA & genotype
by: Waqar A. Al-Kubaisy,
Published: (2011)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
by: Vercauteren, Koen, et al.
Published: (2016)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)